AOP Orphan Pharmaceuticals Aktiengesellschaft
Contact:
AOP
Phone: +43 503 72 44-24
E-Mail: olena.weissenbacher@aoporphan.com
Contact:
AOP
Phone: +43 503 72 44-24
E-Mail: olena.weissenbacher@aoporphan.com
KEYWORDS:
- PV
- Polycythemia Vera
- Ropeginterferon alfa-2b
- PharmaEssentia
- AOP Orphan
attachments to announcement
AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in PV
back to announcementphotos
 [ download press photo ] | title: AOP Orphan Pharmaceuticals AG image text: AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera from 3 abstracts presented at the 22nd Congress of the European Hematology Association (EHA) in Madrid. copyright: AOP Orphan |
 [ download press photo ] | title: PharmaEssentia image text: AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera from 3 abstracts presented at the 22nd Congress of the European Hematology Association (EHA) in Madrid. copyright: PharmaEssentia |
